Skip to main content
Advertisement

Main menu

  • Home
  • Articles
    • Current Issue
    • Fast Forward
    • Latest Articles
    • Special Sections
    • Archive
  • Information
    • Instructions to Authors
    • Submit a Manuscript
    • FAQs
    • For Subscribers
    • Terms & Conditions of Use
    • Permissions
  • Editorial Board
  • Alerts
    • Alerts
    • RSS Feeds
  • Virtual Issues
  • Feedback
  • Submit
  • Other Publications
    • Drug Metabolism and Disposition
    • Journal of Pharmacology and Experimental Therapeutics
    • Molecular Pharmacology
    • Pharmacological Reviews
    • Pharmacology Research & Perspectives
    • ASPET

User menu

  • My alerts
  • Log in
  • My Cart

Search

  • Advanced search
Drug Metabolism & Disposition
  • Other Publications
    • Drug Metabolism and Disposition
    • Journal of Pharmacology and Experimental Therapeutics
    • Molecular Pharmacology
    • Pharmacological Reviews
    • Pharmacology Research & Perspectives
    • ASPET
  • My alerts
  • Log in
  • My Cart
Drug Metabolism & Disposition

Advanced Search

  • Home
  • Articles
    • Current Issue
    • Fast Forward
    • Latest Articles
    • Special Sections
    • Archive
  • Information
    • Instructions to Authors
    • Submit a Manuscript
    • FAQs
    • For Subscribers
    • Terms & Conditions of Use
    • Permissions
  • Editorial Board
  • Alerts
    • Alerts
    • RSS Feeds
  • Virtual Issues
  • Feedback
  • Submit
  • Visit dmd on Facebook
  • Follow dmd on Twitter
  • Follow ASPET on LinkedIn

Table of Contents

September 01, 1991; Volume 19,Issue 5
  • You have access
    The 1990 Bernard B. Brodie Award Lecture. Unique properties of the enzymes of detoxication.
    D M Ziegler
    Drug Metabolism and Disposition September 1991, 19 (5) 847-852;
  • You have access
    Stereoselective disposition of carprofen, flunoxaprofen, and naproxen in rats.
    S Iwakawa, H Spahn, L Z Benet and E T Lin
    Drug Metabolism and Disposition September 1991, 19 (5) 853-857;
  • You have access
    Disposition of RS-26306, a potent luteinizing hormone-releasing hormone antagonist, in monkeys and rats after single intravenous and subcutaneous administration.
    R L Chan, S C Hsieh, P E Haroldsen, W Ho and J J Nestor
    Drug Metabolism and Disposition September 1991, 19 (5) 858-864;
  • You have access
    Excretion and tissue distribution of selenium following treatment of male F344 rats with benzylselenocyanate or sodium selenite.
    O S Sohn, L Blackwell, J Mathis, W W Asaad, B S Reddy and K el-Bayoumy
    Drug Metabolism and Disposition September 1991, 19 (5) 865-870;
  • You have access
    Evidence for oxidative activation of mitoxantrone in human, pig, and rat.
    J Blanz, K Mewes, G Ehninger, B Proksch, D Waidelich, B Greger and K P Zeller
    Drug Metabolism and Disposition September 1991, 19 (5) 871-880;
  • You have access
    Pharmacokinetics of 2-ethyl-1,3-hexanediol. I. Systemic disposition following single intravenous doses in male Fischer 344 rats.
    S W Frantz, C M Grosse, M J Tallant and B Ballantyne
    Drug Metabolism and Disposition September 1991, 19 (5) 881-888;
  • You have access
    Stereoselective metabolism of felodipine in liver microsomes from rat, dog, and human.
    U G Eriksson, J Lundahl, C Bäärnhielm and C G Regårdh
    Drug Metabolism and Disposition September 1991, 19 (5) 889-894;
  • You have access
    In vivo formation of codeinone and morphinone from codeine. Isolation and identification from guinea pig bile.
    T Ishida, M Yano and S Toki
    Drug Metabolism and Disposition September 1991, 19 (5) 895-899;
  • You have access
    Reactions of the nitroso and hydroxylamine metabolites of sulfamethoxazole with reduced glutathione. Implications for idiosyncratic toxicity.
    A E Cribb, M Miller, J S Leeder, J Hill and S P Spielberg
    Drug Metabolism and Disposition September 1991, 19 (5) 900-906;
  • You have access
    Dose dependence in the plasma pharmacokinetics and uptake kinetics of 2',3'-dideoxyinosine into brain and cerebrospinal fluid of rats.
    B L Hoesterey, R E Galinsky and B D Anderson
    Drug Metabolism and Disposition September 1991, 19 (5) 907-912;
  • You have access
    Mass spectrometric identification of urinary and plasma metabolites of 6-(6'-carboxyhexyl)-7-n-hexyl-1,3-diazaspiro-[4-4]-nonan-2,4-dione, a new cytoprotective agent.
    E Benfenati, R Fanelli, E Bosone, C Biffi, R Caponi, M Cianetti and P Farina
    Drug Metabolism and Disposition September 1991, 19 (5) 913-916;
  • You have access
    Metabolism of cinobufagin in rat liver microsomes. Identification of epimerized and deacetylated metabolites by liquid chromatography/mass spectrometry.
    L S Zhang, T Yoshida, K Aoki and Y Kuroiwa
    Drug Metabolism and Disposition September 1991, 19 (5) 917-919;
  • You have access
    Identification of the major metabolites of the prostaglandin E2-analogue sulprostone in human plasma, and isolation from urine (in vivo) and liver perfusate (in vitro) of female guinea-pigs.
    W Kuhnz, G A Hoyer, S Backhus and U Jakobs
    Drug Metabolism and Disposition September 1991, 19 (5) 920-925;
  • You have access
    Physiological disposition of alendronate, a potent anti-osteolytic bisphosphonate, in laboratory animals.
    J H Lin, D E Duggan, I W Chen and R L Ellsworth
    Drug Metabolism and Disposition September 1991, 19 (5) 926-932;
  • You have access
    Acetylator phenotype-dependent and -independent expression of arylamine N-acetyltransferase isozymes in rapid and slow acetylator inbred rat liver.
    D W Hein, T D Rustan, K D Bucher, W J Martin and E J Furman
    Drug Metabolism and Disposition September 1991, 19 (5) 933-937;
  • You have access
    Pharmacokinetics of iododoxorubicin in the rat, dog, and monkey.
    D M Edwards, P Marrari, C Efthymiopoulos, G Basileo, D Fraier, E Pianezzola and M Strolin-Benedetti
    Drug Metabolism and Disposition September 1991, 19 (5) 938-945;
  • You have access
    Nicotine metabolism in stumptailed macaques, Macaca arctoides.
    M Seaton, G A Kyerematen, M Morgan, E V Jeszenka and E S Vesell
    Drug Metabolism and Disposition September 1991, 19 (5) 946-954;
  • You have access
    A nuclear magnetic resonance study of sparteine delta metabolite structure.
    T Ebner, C O Meese, P Fischer and M Eichelbaum
    Drug Metabolism and Disposition September 1991, 19 (5) 955-959;
  • You have access
    First pass metabolism and in vitro metabolism of a new orally active dopamine prodrug, N-(N-acetyl-L-methionyl)-O,O-bis(ethoxycarbonyl)dopamine in dogs.
    M Yoshikawa, S Nishiyama, H Endo, Y Togo and O Takaiti
    Drug Metabolism and Disposition September 1991, 19 (5) 960-965;
  • You have access
    Activation of acetaminophen-reactive metabolite formation by methylxanthines and known cytochrome P-450 activators.
    C A Lee, K E Thummel, T F Kalhorn, S D Nelson and J T Slattery
    Drug Metabolism and Disposition September 1991, 19 (5) 966-971;
  • You have access
    Pharmacokinetic analysis of the disposition of valproate in pregnant rats.
    S Kobayashi, K Takai, T Iga and M Hanano
    Drug Metabolism and Disposition September 1991, 19 (5) 972-976;
  • You have access
    Metabolism of 3-methylindole in human tissues.
    W Ruangyuttikarn, M L Appleton and G S Yost
    Drug Metabolism and Disposition September 1991, 19 (5) 977-984;
  • You have access
    Effect of congestive heart failure on the intrinsic metabolic capacity of the liver in the dog.
    C Lambert, J R Halpert, J Rouleau, L Jutras, V Leroyer and P du Souich
    Drug Metabolism and Disposition September 1991, 19 (5) 985-989;
  • You have access
    Determination of in vivo hepatic extraction ratio from in vitro metabolism by rat hepatocytes.
    K Singh, S L Tripp, A W Dunton, F L Douglas and A Rakhit
    Drug Metabolism and Disposition September 1991, 19 (5) 990-996;
  • You have access
    Partial characterization of biliary metabolites of pulegone by tandem mass spectrometry. Detection of glucuronide, glutathione, and glutathionyl glucuronide conjugates.
    D Thomassen, P G Pearson, J T Slattery and S D Nelson
    Drug Metabolism and Disposition September 1991, 19 (5) 997-1003;
  • You have access
    Metabolism in vivo and in vitro of the refrigerant substitute 1,1,1,2-tetrafluoro-2-chloroethane.
    M J Olson, J T Johnson, J F O'Gara and S E Surbrook
    Drug Metabolism and Disposition September 1991, 19 (5) 1004-1011;
  • You have access
    Product enantioselectivity in the N-glucosylation of amobarbital by cats.
    S E Mongrain and W H Soine
    Drug Metabolism and Disposition September 1991, 19 (5) 1012-1013;
Back to top
PreviousNext

In this issue

Drug Metabolism and Disposition
Vol. 19, Issue 5
1 Sep 1991
  • Table of Contents
  • Index by author
  • Back Matter (PDF)
Sign up for alerts
  • Most Cited
  • Most Read
Loading
  • Cytochrome P450 inhibitors. Evaluation of specificities in the in vitrometabolism of therapeutic agents by human liver microsomes.
  • Prediction of Human Clearance of Twenty-Nine Drugs from Hepatic Microsomal Intrinsic Clearance Data: An Examination of In Vitro Half-Life Approach and Nonspecific Binding to Microsomes
  • DRUG-DRUG INTERACTIONS FOR UDP-GLUCURONOSYLTRANSFERASE SUBSTRATES: A PHARMACOKINETIC EXPLANATION FOR TYPICALLY OBSERVED LOW EXPOSURE (AUCI/AUC) RATIOS
  • In Vitro-In Vivo Scaling of CYP Kinetic Data Not Consistent with the Classical Michaelis-Menten Model
  • THE HUMAN INTESTINAL CYTOCHROME P450 “PIE”
More...
Advertisement
  • Home
  • Alerts
Facebook   Twitter   LinkedIn   RSS

Navigate

  • Current Issue
  • Fast Forward by date
  • Fast Forward by section
  • Latest Articles
  • Archive
  • Search for Articles
  • Feedback
  • ASPET

More Information

  • About DMD
  • Editorial Board
  • Instructions to Authors
  • Submit a Manuscript
  • Customized Alerts
  • RSS Feeds
  • Subscriptions
  • Permissions
  • Terms & Conditions of Use

ASPET's Other Journals

  • Journal of Pharmacology and Experimental Therapeutics
  • Molecular Pharmacology
  • Pharmacological Reviews
  • Pharmacology Research & Perspectives
ISSN 1521-009X (Online)

Copyright © 2023 by the American Society for Pharmacology and Experimental Therapeutics